Effectiveness of interval nitrate therapy in angina pectoris.
Because of rapid tolerance development, the use of multiple daily doses of oral nitrates or continuous application of transdermal nitrate systems can no longer be considered justified. Only with an interval treatment, which prevents nitrate accumulation in the plasma such that, from low baseline values, renewed administration of the drug results in a marked increase in plasma concentration, is it possible to utilize the antianginal and antiischaemic effects of nitrates for meaningful long-term treatment. For isosorbide dinitrate and isosorbide 5-mononitrate, as well as for transdermal nitroglycerin systems, interval treatment dosing regimens with maintained effectiveness documented in controlled studies have been delineated. To some degree, the principle of interval treatment can be achieved with continuously applied transdermal patches designed for discontinuous release of their content, which yield maintained though somewhat attenuated effects. Recent studies have shown that the tolerance to nitroglycerin, which develops within the first 12h of contact with currently available transdermal patches, can be prevented by gradually increasing the plasma concentration during this period of time. Evidence for clinically relevant rebound phenomena during interval treatment has not been observed.
Rudolph
W
W
Department of Cardiology, German Heart Center, Munich, F.R.G.
Dirschinger
J
J
Hall
D
D
Reiniger
G
G
Bayeric
A
A
D000279:Administration, Cutaneous; D000787:Angina Pectoris / Q000188:drug therapy*; D004334:Drug Administration Schedule; D004361:Drug Tolerance; D006801:Humans; D007548:Isosorbide Dinitrate / Q000008:administration & dosage / Q000031:analogs & derivatives; D009566:Nitrates / Q000008:administration & dosage* / Q000627:therapeutic use; D005996:Nitroglycerin / Q000008:administration & dosage
D009566:Nitrates; D005996:Nitroglycerin; D007548:Isosorbide Dinitrate; C030397:isosorbide-5-mononitrate